Characterizing the COVID-19 Illness Experience to Inform the Study of Post-acute Sequelae and Recovery.

Autor: Santiago-Rodriguez EI; Center for AIDS Prevention Studies, University of California, San Francisco, 550 16th Street, 3rd Floor, San Francisco, CA, 94158, USA., Maiorana A; Center for AIDS Prevention Studies, University of California, San Francisco, 550 16th Street, 3rd Floor, San Francisco, CA, 94158, USA., Peluso MJ; Division of HIV, ID and Global Medicine, University of California, San Francisco, San Francisco, CA, USA., Hoh R; Division of HIV, ID and Global Medicine, University of California, San Francisco, San Francisco, CA, USA., Tai V; Division of HIV, ID and Global Medicine, University of California, San Francisco, San Francisco, CA, USA., Fehrman EA; Division of HIV, ID and Global Medicine, University of California, San Francisco, San Francisco, CA, USA., Hernandez Y; Division of HIV, ID and Global Medicine, University of California, San Francisco, San Francisco, CA, USA., Torres L; Division of HIV, ID and Global Medicine, University of California, San Francisco, San Francisco, CA, USA., Spinelli MA; Division of HIV, ID and Global Medicine, University of California, San Francisco, San Francisco, CA, USA., Gandhi M; Division of HIV, ID and Global Medicine, University of California, San Francisco, San Francisco, CA, USA., Kelly JD; Division of HIV, ID and Global Medicine, University of California, San Francisco, San Francisco, CA, USA., Martin JN; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA., Henrich TJ; Division of Experimental Medicine, University of California, San Francisco, San Francisco, CA, USA., Deeks SG; Division of HIV, ID and Global Medicine, University of California, San Francisco, San Francisco, CA, USA., Sauceda JA; Center for AIDS Prevention Studies, University of California, San Francisco, 550 16th Street, 3rd Floor, San Francisco, CA, 94158, USA. john.sauceda@ucsf.edu.
Jazyk: angličtina
Zdroj: International journal of behavioral medicine [Int J Behav Med] 2022 Oct; Vol. 29 (5), pp. 610-623. Date of Electronic Publication: 2021 Dec 16.
DOI: 10.1007/s12529-021-10045-7
Abstrakt: Background: There is an urgent need to fully understand the impact of variable COVID-19 experiences and the optimal management of post-acute sequelae of SARS-CoV-2 infection. We characterized the variability in the acute illness experience and ongoing recovery process from participants in a COVID-19 recovery cohort study in Northern California in 2020.
Method: We completed 24 semi-structured in-depth interviews with adults with confirmed positive SARV-CoV-2 nucleic acid amplification test result, had recovered or were recovering from acute infection, and underwent serial evaluations. We purposefully sampled English- and Spanish-speaking adults with asymptomatic, mild, and severe symptomatic infection, including those who were hospitalized and those with HIV co-infection. We used a thematic analysis to analyze interviews and identify salient themes.
Results: After integrating the thematic analysis with clinical data, we identified key themes: (1) across symptom profiles and severity, experiencing COVID-19 was associated with psychological distress; (2) symptomatic infection carried uncertainty in symptom presentation and ongoing recovery (e.g., long COVID); and (3) health information-seeking behavior was facilitated by access to medical care and uncertainty with the recovery process.
Conclusion: Our data informs the emerging field of "long COVID" research and shows a need to provide information and continuous support to persons with post-acute sequelae to ensure they feel secure along the path to recovery.
(© 2021. International Society of Behavioral Medicine.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje